Geneva– On World AIDS Day the World Health Organization (WHO) emphasizes that expanding antiretroviral therapy to all people living with HIV is key to ending the AIDS epidemic within a generation. “The Millennium Development Goal of reversing the HIV epidemic was reached ahead of the…
Measles vaccination has saved an estimated 17.1 million lives since 2000 But, 2015 global milestones and measles elimination goals are off track 12 November 2015 | Geneva – The number of measles-related deaths has decreased 79% from 546 800 at the beginning of the century…
Note to Correspondents re plans to mark end of Ebola transmission in Sierra Leone On Behalf of the Sierra Leone National Ebola Response Centre (NERC) and the World Health Organization (WHO) On 7 November 2015, if no new case of Ebola virus disease is recorded,…
The fight against tuberculosis is paying off, with this year’s death rate nearly half of what it was in 1990. Nevertheless, 1.5 million people died from TB in 2014. Most of these deaths could have been prevented, according to the World Health Organization’s Global Tuberculosis…
Preliminary results of a study into persistence of Ebola virus in body fluids show that some men still produce semen samples that test positive for Ebola virus nine months after onset of symptoms. The report, published today in the New England Journal of Medicine, provides…
30 September 2015: Geneva -Anyone infected with HIV should begin antiretroviral treatment as soon after diagnosis as possible, the World Health Organization (WHO) announced Wednesday. With its "treat-all" recommendation, WHO removes all limitations on eligibility for antiretroviral therapy (ART) among people living with HIV; all…
Only two countries remain endemic to this paralysing disease The World Health Organization announced today that polio is no longer endemic in Nigeria. This is the first time that Nigeria has interrupted transmission of wild poliovirus, bringing the country and the African region closer than…
GENEVA: 18 AUGUST 2015 - People who delay or refuse vaccines for themselves or their children are presenting a growing challenge for countries seeking to close the immunization gap. Globally, one in 5 children still do not receive routine life-saving immunizations, and an estimated 1.5…
Geneva, 31 July 2015 – Results from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola. The independent body of international experts - the Data and Safety Monitoring Board – that…
International partners call for immediate increase in vaccine production to ward off danger 28 JULY 2015 | GENEVA - With Africa at risk of a large meningitis outbreak, an acute shortage of meningitis C-containing vaccine threatens to severely limit the world's ability to minimize the…